Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Of Nuclear Energy Atomic Energy CouncilfiledCriticalInst Of Nuclear Energy Atomic Energy Council
Priority to TW83109828ApriorityCriticalpatent/TW291440B/en
Application grantedgrantedCritical
Publication of TW291440BpublicationCriticalpatent/TW291440B/en
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Abstract
This invention relates to novel tumor imaging agents in which the dimercaptosuccinic acid was dissolved in phosphate buffer and labelled with radioisotope gallium. The product of gallium dimercaptosuccinate has been characterized by a variety of experiments including serum stability, biodistribution and imaging experiment. As the results, the compound of gallium dimercaptosuccinate has been confirmed as a novel radiopharmaceutical for tumor imaging agent.
TW83109828A1994-10-241994-10-24Gallium dimercaptosuccinate as novel tumor imaging agents
TW291440B
(en)
Radiolabeled compound as imaging agents for the diagnosis of arterial and venous thrombi, radiopharmaceuticals and radiopharmaceutical composition and kits for its preparation